• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达恶性疟原虫环子孢子蛋白的伤寒沙门氏菌疫苗株CVD 908:菌株构建及其在人体中的安全性和免疫原性

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.

作者信息

Gonzalez C, Hone D, Noriega F R, Tacket C O, Davis J R, Losonsky G, Nataro J P, Hoffman S, Malik A, Nardin E, Sztein M B, Heppner D G, Fouts T R, Isibasi A, Levine M M

机构信息

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore 21201.

出版信息

J Infect Dis. 1994 Apr;169(4):927-31. doi: 10.1093/infdis/169.4.927.

DOI:10.1093/infdis/169.4.927
PMID:8133113
Abstract

rcsp, encoding amino acids 21-398 of Plasmodium falciparum circumsporozoite protein (CSP), under control of tacP was integrated into the chromosomal delta aroC locus of attenuated delta aroC, delta aroD Salmonella typhi CVD 908. By immunoblot and ELISA, rCSP expression was greater from a multicopy plasmid than from the single chromosomal gene. CVD 908 omega (delta aroC1019::tacP-rcsp) was well tolerated by 10 volunteers who were fed two doses of 5 x 10(7) organisms 8 days apart. Seven subjects excreted the vaccine strain for 1-3 days. All subjects developed serologic responses to O and H antigens of the live vector, whereas 3 vaccinees responded to the foreign antigen: 1 developed an 80-fold rise in serum anti-sporozoite antibody, another had a 4-fold rise in antibody to a recombinant portion of CSP (residues 309-345), while a third vaccinee developed CSP-specific CD8+ cytotoxic T lymphocyte activity. This is the first report of attenuated S. typhi eliciting a human serologic or a cytotoxic T lymphocyte response to a foreign protein. Improved foreign gene expression should enhance immunogenicity.

摘要

在 tacP 的控制下,编码恶性疟原虫环子孢子蛋白(CSP)第 21 - 398 位氨基酸的 rcsp 被整合到减毒的 aroC 缺失、aroD 缺失的伤寒沙门氏菌 CVD 908 的染色体 aroC 缺失位点。通过免疫印迹和酶联免疫吸附测定,多拷贝质粒中的 rCSP 表达量高于单染色体基因中的表达量。10 名志愿者间隔 8 天口服两剂 5×10⁷ 个生物体剂量的 CVD 908 omega(aroC1019 缺失::tacP - rcsp)后耐受性良好。7 名受试者排出疫苗菌株 1 - 3 天。所有受试者对活载体的 O 和 H 抗原产生了血清学反应,而 3 名接种者对外源抗原产生了反应:1 名接种者血清抗子孢子抗体升高了 80 倍,另一名接种者对 CSP 的重组部分(第 309 - 345 位氨基酸残基)的抗体升高了 4 倍,第三名接种者产生了 CSP 特异性 CD8⁺ 细胞毒性 T 淋巴细胞活性。这是减毒伤寒沙门氏菌引发人体对外源蛋白的血清学或细胞毒性 T 淋巴细胞反应的首次报道。改善的外源基因表达应能增强免疫原性。

相似文献

1
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans.表达恶性疟原虫环子孢子蛋白的伤寒沙门氏菌疫苗株CVD 908:菌株构建及其在人体中的安全性和免疫原性
J Infect Dis. 1994 Apr;169(4):927-31. doi: 10.1093/infdis/169.4.927.
2
Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.通过采用表达恶性疟原虫环子孢子蛋白(PfCSP)的伤寒沙门氏菌血清型 Typhi 和编码 PfCSP 的 DNA 疫苗进行异源初免-加强策略,增强对 PfCSP 的免疫力。
Infect Immun. 2007 Aug;75(8):3769-79. doi: 10.1128/IAI.00356-07. Epub 2007 May 14.
3
Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana.表达墨西哥利什曼原虫主要表面蛋白gp63的伤寒沙门氏菌CVD 908候选疫苗株的免疫原性。
Vaccine. 1998 May-Jun;16(9-10):1043-52. doi: 10.1016/s0264-410x(97)00267-3.
4
Construction of a tetR-integrated Salmonella enterica serovar Typhi CVD908 strain that tightly controls expression of the major merozoite surface protein of Plasmodium falciparum for applications in human Vaccine production.构建一种整合了tetR的伤寒沙门氏菌血清型Typhi CVD908菌株,该菌株可严格控制恶性疟原虫主要裂殖子表面蛋白的表达,用于人类疫苗生产。
Infect Immun. 2002 Apr;70(4):2029-38. doi: 10.1128/IAI.70.4.2029-2038.2002.
5
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.1期随机对照试验,评估重组毕赤酵母表达的恶性疟原虫顶端膜抗原1(PfAMA1-FVO [25-545])在班迪亚加拉健康马里成年人中的安全性和免疫原性。
Malar J. 2016 Aug 30;15(1):442. doi: 10.1186/s12936-016-1466-4.
6
[Production and molecular characterization of Plasmodium falciparum recombinant circumsporozoite protein with 37 NANP and 4 NVDP epitopes].[具有37个NANP和4个NVDP表位的恶性疟原虫重组环子孢子蛋白的生产及分子特征分析]
Mikrobiyol Bul. 2017 Jan;51(1):41-51. doi: 10.5578/mb.46549.
7
Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL.利用自转运蛋白MisL在肠炎沙门氏菌表面表达恶性疟原虫免疫显性表位(NANP)₄
Infect Immun. 2002 Jul;70(7):3611-20. doi: 10.1128/IAI.70.7.3611-3620.2002.
8
Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.重组生产的恶性疟原虫环子孢子蛋白-乙型肝炎表面抗原亚单位疫苗的安全性、免疫原性和有效性。
J Infect Dis. 1995 Jun;171(6):1576-85. doi: 10.1093/infdis/171.6.1576.
9
Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.一种由表达恶性疟原虫环子孢子表位的乙型肝炎病毒核心颗粒组成的疟疾疫苗的I期试验。
Infect Immun. 2004 Nov;72(11):6519-27. doi: 10.1128/IAI.72.11.6519-6527.2004.
10
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component.腺病毒 5 型载体疟疾疫苗表达 CSP 和 AMA1。B 部分:CSP 成分的安全性、免疫原性和保护效力。
PLoS One. 2011;6(10):e25868. doi: 10.1371/journal.pone.0025868. Epub 2011 Oct 7.

引用本文的文献

1
Needle-free, spirulina-produced Plasmodium falciparum circumsporozoite vaccination provides sterile protection against pre-erythrocytic malaria in mice.无针、螺旋藻产生的恶性疟原虫环子孢子蛋白疫苗可在小鼠中提供针对红细胞前期疟疾的无菌保护。
NPJ Vaccines. 2022 Oct 4;7(1):113. doi: 10.1038/s41541-022-00534-5.
2
Strategies for Enhancement of Live-Attenuated -Based Carrier Vaccine Immunogenicity.增强基于减毒活疫苗载体免疫原性的策略。
Vaccines (Basel). 2021 Feb 17;9(2):162. doi: 10.3390/vaccines9020162.
3
Prospects for Malaria Vaccines: Pre-Erythrocytic Stages, Blood Stages, and Transmission-Blocking Stages.
疟疾疫苗的前景:红细胞前期、红内期和传播阻断期。
Biomed Res Int. 2019 Oct 3;2019:9751471. doi: 10.1155/2019/9751471. eCollection 2019.
4
Vaccination With Sporozoites: Models and Correlates of Protection.疟原虫疫苗:保护的模型和相关性。
Front Immunol. 2019 Jun 5;10:1227. doi: 10.3389/fimmu.2019.01227. eCollection 2019.
5
Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates.人隐孢子虫基因目录:一种用于筛选新型隐孢子虫疫苗候选物的资源。
Database (Oxford). 2016 Oct 19;2016. doi: 10.1093/database/baw137. Print 2016.
6
Plague Vaccines: Status and Future.鼠疫疫苗:现状与未来
Adv Exp Med Biol. 2016;918:313-360. doi: 10.1007/978-94-024-0890-4_12.
7
Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward.人类对肠热病的复杂适应性免疫:经验教训与未来方向
Front Immunol. 2014 Oct 27;5:516. doi: 10.3389/fimmu.2014.00516. eCollection 2014.
8
Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines.携带艾滋病毒/艾滋病疫苗的重组沙门氏菌载体
Open Virol J. 2013 Dec 30;7:121-6. doi: 10.2174/1874357901307010121. eCollection 2013.
9
Novel methods for expression of foreign antigens in live vector vaccines.活载体疫苗中外源抗原表达的新方法。
Hum Vaccin Immunother. 2013 Jul;9(7):1558-64. doi: 10.4161/hv.23248. Epub 2013 Feb 13.
10
New dimensions in vaccinology: A new insight.疫苗学的新维度:一种新见解。
Indian J Clin Biochem. 2005 Jan;20(1):213-30. doi: 10.1007/BF02893073.